Warrior CARE: Cannabis Behavioral Health

Part of paid clinical trials in Detroit, Michigan.

Sponsor
Wayne State University
Study ID
NCT06381180
Phase
PHASE1/PHASE2
Status
Recruiting

Conditions

Eligibility Criteria

Sex
ALL
Age
19 Years - 69 Years
Healthy Volunteers
Not accepted

Interventions

  • Tetrahydrocannabinol — DRUG
    Plant cannabis that will be smoked
  • Cannabidiol — DRUG
    Plant cannabidiol that will be smoked
  • Placebo — DRUG
    Plant will be smoked.

Study Details

This study is a randomized, controlled clinical trial to examine the therapeutic potential of cannabinoids for treating veterans with PTSD and suicidal ideation.

Key Dates

First listed
Apr 24, 2024
Start date
Sep 22, 2025
Status verified
Aug 2026
Primary completion
Dec 31, 2030
Completion
Dec 31, 2030

Study Design

Enrollment
500 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Experimental: THC Group
    Cannabis with 5 mg THC; up to a maximum of 5 doses/day (max dose = 25 mg THC)
  • Experimental: CBD Group
    Cannabis with 5 mg CBD; up to a maximum of 5 doses/day (max dose = 25 mg CBD)
  • Experimental: THC & CBD Group
    Cannabis with 5 mg THC and 5 mg CBD; up to a maximum of 5 doses/day (max doses = 25 mg THC and 25 mg CBD)
  • Active Comparator: Placebo Group
    Cannabis with \<1mg THC and \<1mg CBD; up to a maximum of 5 doses/day (max dose = \<5 mg THC and \<5 mg CBD)

Primary Outcome Measure

Assessing change in PTSD diagnosis and its symptom severity from pre-treatment to post-treatment using the CAPS-5 assessment. [ Time Frame: Administered at a pre-treatment visit (at the initial screening visit); and at the four post-treatment visits (one week post-treatment and 3-, 6-, and 9-months post-treatment visits). ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Wayne State UniversityDetroitMichigan48201
Paula Qefaliaj, B.S.
2486881251

Find similar trials in Detroit, MI

Related Studies